Chinese Journal of Tissue Engineering Research ›› 2023, Vol. 27 ›› Issue (19): 3070-3076.doi: 10.12307/2023.659

Previous Articles    

Mechanism of Rehmannia glutinosa combined with mesenchymal stem cells in treating ischemic stroke

Wei Zhihui, Liu Feixiang, Pan Xiaolong, Sun Shibiao, Zhang Yunke   

  1. Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
  • Received:2022-08-01 Accepted:2022-09-24 Online:2023-07-08 Published:2022-11-28
  • Contact: Zhang Yunke, MD, Professor, Chief physician, Doctoral supervisor, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China
  • About author:Wei Zhihui, Master candidate, Henan University of Chinese Medicine, Zhengzhou 450046, Henan Province, China
  • Supported by:
    the National Natural Science Foundation of China, Nos. 81974564 (to ZYK) and 82104730 (to LFX); Central Plains Talent Plan-Science and Technology Innovation Leading Talents Project, No. 224200510027 (to ZYK)

PDF

1342

Abstract: BACKGROUND: Rehmannia glutinosa has the effects of inhibiting oxidative stress, inhibiting apoptosis, inhibiting nerve inflammation, promoting angiogenesis and anti-aging, and has unique advantages in the treatment of ischemic stroke. The combination of Rehmannia glutinosa with mesenchymal stem cells as a carrier can play a better role in the treatment of ischemic stroke.  
OBJECTIVE: To review the research progress of Rehmannia glutinosa combined with mesenchymal stem cells in the treatment of ischemic stroke.
METHODS: We searched CNKI and PubMed for the literature on the treatment of senile ischemic stroke with Rehmannia glutinosa combined with mesenchymal stem cells from 2012 to 2022. The keywords were “Rehmannia, mesenchymal stem cells (MSCs), ischemic stroke” in Chinese and English, respectively. Finally, 86 articles were included for further review.  
RESULTS AND CONCLUSION: (1) The mechanisms of mesenchymal stem cells in the treatment of ischemic stroke were reviewed, including the promotion of cell migration and differentiation, immunomodulation, and inhibition of apoptosis. (2) The mechanisms of Rehmannia glutinosa in treating ischemic stroke were summarized, including inhibition of oxidative stress, inhibition of nerve inflammation, inhibition of apoptosis, promotion of neuroangiogenesis, and anti-aging. (3) Rehmannia glutinosa could stimulate the vitality of mesenchymal stem cells, promote the proliferation of mesenchymal stem cells, induce the differentiation of mesenchymal stem cells into neuron-like cells, and improve the survival rate of mesenchymal stem cells in vivo, so as to achieve the goal of synergistic treatment of ischemic stroke. (4) The mechanism of Rehmannia glutinosa combined with mesenchymal stem cells in the treatment of ischemic stroke was summarized, including inhibition of oxidative stress, inhibition of apoptosis, anti-aging, promotion of angiogenesis and nerve remodeling, thereby providing theoretical reference for the new treatment of ischemic stroke in the future.

Key words: stem cell, Rehmannia glutinosa, compound, mesenchymal stem cell, ischemic stroke, anti-aging, angiogenesis, nerve remodeling, review

CLC Number: